This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Medical Crossfire<sup>®</sup>: Residual Inflammatory Risk in Atherosclerosis: Clinical Pearls for Clinicians

Medical Crossfire®: Residual Inflammatory Risk in Atherosclerosis: Clinical Pearls for Clinicians

Format

Roundtable

Time to Complete

1 hour

Released

June 15, 2017

Expires

June 15, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CE for Nurse Practitioners

Accredited Provider

Jointly provided by Global Education Group and Physicians' Education Resource®, LLC (PER®)

Commercial Supporter

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Program Description

Atherosclerosis, formerly considered a bland lipid storage disease, actually involves an ongoing inflammatory response. Recent advances in basic science have established a fundamental role for inflammation in mediating all stages of this disease from initiation through progression and, ultimately, the thrombotic complications of atherosclerosis. These new insights into inflammation in atherosclerosis not only increase our understanding of this disease, but also have practical clinical applications in risk stratification and targeting of therapy for this scourge of growing worldwide importance.

Intended Audience

Physicians, nurse practitioners, and physician assistants involved in the care of patients with inflammation

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Articulate the role of inflammation in the pathogenesis of atherosclerosis
  • Describe best practices for incorporating inflammatory biomarkers into cardiovascular risk assessment procedures to prevent secondary cardiovascular disease (CVD) risk
  • List the pleiotropic effects of statins, specifically their anti-inflammatory properties
  • Summarize recent data on emerging agents that target inflammation for secondary prevention of CVD in order to provide optimal outcomes for patients at risk

Disclosure of Conflicts of Interest Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty

Christie M. Ballantyne, MD
Professor of Medicine, Department of Medicine
Chief, Section of Cardiology
Chief, Section of Cardiovascular Research
Baylor College of Medicine

Director, Center for Cardiovascular Disease Prevention
DeBakey Heart and Vascular Center
Houston Methodist Hospital
Houston, TX

Dr. Ballantyne has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Abbott Diagnostic, Amarin, Amgen, Esperion, Ionis, Novartis, Pfizer, Regeneron, Roche Diagnostic, Sanofi-Synthelabo, NIH, AHA, and ADA
Consultant: Abbott Diagnostics, Amarin, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Esperion, Ionis, Matinas BioPharma Inc, Merck, Novartis, Pfizer, Regeneron, Roche Diagnostic, and Sanofi-Synthelabo

Peter Libby, MD
Brigham and Women’s Hospital
Cardiovascular Medicine
Harvard Medical School
Boston, MA

Dr. Libby has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Novartis
Consultant: Novartis

Paul M. Ridker, MD
Eugene Braunwald Professor of Medicine
Harvard Medical School
Director, Center for Cardiovascular Disease Prevention
Brigham and Women’s Hospital
Boston, MA

Dr. Ridker has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: AstraZeneca, Novartis, Pfizer, Kowa, and Amgen
Consultant: Sanofi, Quintiles, AstraZeneca, and TEVA
Patents Licensed: Siemen, AstraZeneca
Research Funding Support: National Lung, Heart and Blood Institute, The National Cancer Institute, The American Heart Association, The Doris Duke Charitable Foundation, The Leducq Foundation, The Donald W Reynolds Foundation, and The James and Polly Annenberg La Vea Charitable Trusts

Robert S. Rosenson, MD
Director, Cardiometabolics Unit
Mount Sinai Hospital
Professor of Medicine (Cardiology)
Icahn School of Medicine at Mount Sinai
New York, NY

Dr. Rosenson has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Akcea, Amgen, AstraZeneca, Esperion, Medicines Company, and Regeneron
Consultant: Amgen, CVS Caremark, C5, Regeneron, and Sanofi
Honoraria: Kowa
Other: UpToDate, Inc.

Accredited Provider Disclosure

Global Education Group Planners/Managers: Kristen Delisi, NP, Amanda Glazar, PhD, Laura Gilsdorf, and Andrea Funk have no relevant financial relationships with commercial interests to disclose.

Publishing Staff Disclosures

Physicians' Education Resource®, LLC (PER®)
Planning Staff: David Heckard, Maryjo Dixon, RPh, Donna Fausak, and Nicole Grassano have no relevant financial relationships with commercial interests to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physicians' Education Resource®, LLC (PER®). Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurse Practitioners

Accreditation Statement


Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024

Designation Statement

This activity is accredited for 1.00 contact hour which includes 0.00 hour(s) of pharmacology.

Activity ID 2239E

This activity was planned in accordance with AANP CE Standards and Policies.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PER do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

There is no fee for this educational activity.

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue